Sabatini Brent has filed 10 insider transactions across 1 company since February 2025.
Most recent transaction: a sale of 7711 shares of Vir Biotechnology, Inc. ($VIR) on March 23, 2026.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | S | Common Stock | 7711 | $9.12 | 61,902.0000 | 139,125,032 | 11.08% | 0.01% |
| Feb. 24, 2026 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | S | Common Stock | 1430 | $9.53 | 69,613.0000 | 139,125,032 | 2.01% | 0.00% |
| Feb. 22, 2026 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | A | Common Stock | 25000 | $0.00 | 72,872.0000 | 139,125,032 | 52.22% | 0.02% |
| Feb. 22, 2026 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 139,125,032 | 9999.99% | 0.04% |
| Feb. 23, 2026 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | S | Common Stock | 1829 | $7.45 | 71,043.0000 | 139,125,032 | 2.51% | 0.00% |
| Feb. 13, 2026 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | S | Common Stock | 1530 | $7.79 | 47,872.0000 | 139,125,032 | 3.10% | 0.00% |
| Feb. 22, 2025 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | A | Common Stock | 20000 | $0.00 | 48,189.0000 | 137,143,286 | 70.95% | 0.01% |
| Feb. 22, 2025 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 137,143,286 | 9999.99% | 0.03% |
| Feb. 24, 2025 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | S | Common Stock | 1562 | $9.45 | 46,627.0000 | 137,143,286 | 3.24% | 0.00% |
| Feb. 13, 2025 | Vir Biotechnology, Inc. | $VIR | Sabatini Brent | SVP, Chief Accounting Officer | S | Common Stock | 1562 | $9.15 | 28,189.0000 | 0 | 5.25% | 0.00% |